Neuropsychiatry and genomics

The Neuropsychiatry and genomics working group aim to investigate the range of psychiatric disorders resulting from COVID-19 and their potential mechanisms. Working with experts from across the UK from the full spectrum of relevant clinical and academic neurosciences we hope to answer these key questions to better understand and treat these important complications of COVID-19.

Leads

• Professor Gerome Breen, King's College London
• Dr Tim Nicholson, King's College London.

Members

• Dr Jay Amin, University of Southampton
• Professor Matthew Broome, Birmingham University
• Professor Ed Bullmore, University of Cambridge
• Dr Matt Butler, King’s College London
• Professor Alan Carson, Edinburgh University
• Professor Jonathan Cavanagh, University of Glasgow
• Dr David Christmas, Dundee University
• Professor Anthony David, University College London
• Professor Neil Harrison, Cardiff University
• Dr Matthew Hotopf, King’s College London
• Dr Gabriella Lewis, South London and Maudsley NHS Foundation Trust
• Dr Ryan McIlwaine, Queen’s University Belfast
• Dr Ciaran Mulholland, Queen’s University Belfast
• Dr Akshay Nair, King’s College London
• Dr Alish Palmos, King’s College London
• Dr Tom Pollak, King’s College London
• Professor John Paul Taylor, Newcastle University
• Professor Nicholas Wood, University College London.